Updates

Innovaderma - All time record quarter

May 2017

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

The already exhilarating pace of change is quickening with Innovaderma reporting that January and March achieved the highest-ever monthly revenues and Q3 achieved its highest ever quarterly revenues. In the UK, Skinny Tan recorded an outstanding performance in Superdrug where it became the No.1 selling brand in its category. Growth continues to be driven by the Direct to Consumer strategy where it is using a range of online marketing techniques on Facebook to run hundreds of campaigns simultaneously. These direct people to buy from its own website or from Superdrug.In North America DTC has begun contributing strongly. IDP has secured distribution of Skinny Tan with European beauty retailers Feelunique and Lookfantastic.c ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Midwich

Treatt - To exceed even recently upgraded forecasts

InnovaDerma (October 2018)

InnovaDerma (June 2018)

InnovaDerma - Soon-to-be prospective PE of 10.6 (March 2018)

Innovaderma - Shares look unduly depressed (December 2017)

Innovaderma (November 2017)

Innovaderma (October 2017)

Innovaderma - Broker calls up shares to 600p (July 2017)

Innovaderma (June 2017)

Innovaderma - Beauty of the internet age (March 2017)

Innovaderma (February 2017)

Innovaderma - An enigma (January 2017)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X